Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Skin Care Firms Get External Analgesic Treatment In FDA Warning Letters

Jun 18 2019

• By Malcolm Spicer

WarningSign_1200x675

Related Content

Monograph Reform Legislation In Play As FDA, OTC Industry Get Real On Changes

May 23 2019

ICMAD: Federal Cosmetics Legislation Without National Uniformity Not In Industry’s Interest

Apr 10 2019

Sunscreen Industry Finds Ally In Florida State Senator Hutson; SB 588 Would Ban Local Bans

Apr 05 2019

Additional Topics

United States Cosmetics Dietary Supplements Regulation Advertising, Marketing & Sales Commercial Companies Compliance Distribution Enforcement FDA Ingredients Manufacturing Policy Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window